Agilent Technologies Inc (A) Stock Price Today
Aura AI Summary
Key Stats
- $42.68BMarket Cap
- -Volume
- HealthSector
- $158.9352W High
- $110.2452W Low
- -Typical Hold Time
- $44.87BEnterprise Value
- 0.67%Div Yield
- -Trading Activity
Track Agilent Technologies Inc (A) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Agilent Technologies Inc has traded between a low of $110.24 and a high of $158.93, highlighting its annual price range. Buy and sell Agilent Technologies Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Most Recent News
Teladoc Health cuts 2026 revenue forecast amid insider stock sale and BetterHelp struggles
Teladoc Health's BetterHelp segment saw an 11.6% revenue drop and a near-zero profit margin in Q2 2026, partly due to a shift from cash to insurance payments. The company lowered its full-year 2026 revenue guidance to $2.36-$2.45 billion from $2.48-$...
Estée Lauder announces leadership changes amid insider stock sale and high valuation metrics.
Estée Lauder Companies recently appointed new brand leaders, signaling strategic shifts in its competitive beauty market. An insider executive sold 7,766 shares worth over $802,000, leaving no remaining holdings. The company shows a high P/E ratio of...
US Treasury interventions fail to fix dollar and debt issues; gold seen as the ultimate beneficiary.
The US Treasury's recent interventions targeting the yen and long-term bond yields have had little lasting impact on the dollar or debt market problems, says Adrian Day of Adrian Day Asset Management. The Treasury's bond buyback program, despite doub...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.